📰 Safer Technologies Program News
Page 2 - Safer Technologies Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Safer Technologies Program. Real-time updates on events, politics, business and more.
August 23, 2022
The company’s net profit slid 57 per cent to $3.7 million, while revenue leapt 17 per cent to $120.3 million, as more hospitals adopted its disinfection device.
August 23, 2022
Nanosonics Limited (OTCPK:NNCSF) Q4 2022 Earnings Conference Call August 22, 2022 21:00 ET Company Participants Michael Kavanagh - Managing Director and Chief Executive Officer McGregor...
August 16, 2022
Companies often come to us when they feel that they are ready to submit their medical device to the FDA for clearance or approval, but Medical Technology newcomers may not realize the...
May 18, 2022
Device reduces the spread of infection from patients to clinicians during aerosol generating procedures like intubation of COVID-19 patients, among othersHOUSTON, TX / ACCESSWIRE / May 18, 2022 / Proxima
May 16, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
April 13, 2022
Also: Pear Therapeutics receives FDA SteP designation for its product candidate focused on acute and chronic pain, and Carbon Health launches its diabetes management program.
February 3, 2022
SAN FRANCISCO, Calif. (PRWEB) February 03, 2022 -- (February 3, 2022) Lover, the digital therapeutic app for improving users’ sex lives and treating sexual
December 1, 2021
Falls Church, VA (PRWEB) December 01, 2021 -- Special Pathways for Innovative Devices: A Guide to the FDA’s Breakthrough Device and Safer Technologies
October 26, 2021
/PRNewswire/ -- MCRA, LLC, a leading medical device, in-vitro diagnostic, and biologics advisory firm and clinical research organization (CRO) integrating U.S....
March 11, 2021
Med Device Online - March 10, 2021 The pandemic year of 2020 presented FDA with many enormous challenges, including how to use emergency authorizations to approve diagnostic tests, personal protective equipment, and therapies, how to conduct remote inspections, and what accommodations should be made for clinical trials disrupted by COVID-19. On top of that, FDA found itself facing an enormous and unprecedented amount of political pressure, with its actions, or lack thereof, potentially altering...